Wu JY - Search Results

1

A systematic review of gemcitabine and taxanes combination therapy randomized trials for metastatic breast cancer.

Hu Q, Jiang JX, Luo L, Yang X, Lin X, Dinglin XX, Zhang W, Wu JY, Yao HR. Hu Q, et al. Among authors: wu jy. Springerplus. 2014 Jun 11;3:293. doi: 10.1186/2193-1801-3-293. eCollection 2014. Springerplus. 2014. PMID: 26034661 Free PMC article.

2

Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy.

Rao N, Qiu J, Wu J, Zeng H, Su F, Qiu K, Wu J, Yao H. Rao N, et al. Chemotherapy. 2017;62(4):246-255. doi: 10.1159/000470900. Epub 2017 May 5. Chemotherapy. 2017. PMID: 28472798

3

An Open-Label, Randomized, 2-Way, Crossover Bioequivalence Study of Cefradine Capsules in Healthy Chinese Volunteers.

Lai X, Ye S, Chen L, Chen J, Zhang N, Zhang Y, Wu J, Yao H. Lai X, et al. Clin Pharmacol Drug Dev. 2021 Dec;10(12):1478-1484. doi: 10.1002/cpdd.991. Epub 2021 Jun 20. Clin Pharmacol Drug Dev. 2021. PMID: 34148297 Clinical Trial.

4

Biomarkers of PEGylated Liposomal Doxorubicin-Induced Hypersensitivity Reaction in Breast Cancer Patients Based on Metabolomics.

Zhuang W, Lai X, Mai Q, Ye S, Chen J, Liu Y, Wang J, Li S, Huang Y, Qin T, Hu H, Wu J, Yao H. Zhuang W, et al. Front Pharmacol. 2022 Apr 21;13:827446. doi: 10.3389/fphar.2022.827446. eCollection 2022. Front Pharmacol. 2022. PMID: 35529437 Free PMC article.

5

Meta-analysis of randomized controlled trials for the incidence and risk of treatment-related mortality in patients with breast cancer treated with HER2 blockade.

Wu J, Qiu K, Zhu J, Li J, Lin Y, He Z, Li G. Wu J, et al. Breast. 2015 Dec;24(6):699-704. doi: 10.1016/j.breast.2015.08.006. Epub 2015 Sep 12. Breast. 2015. PMID: 26376461

6

Meta-analysis of randomized controlled trials for the incidence and risk of fatal adverse events in cancer patients treated with ipilimumab.

Zhu J, Wu J, Li G, Li J, Lin Y, He Z, Su C, Zhao W, Wu Q, Chen Z, Qiu K. Zhu J, et al. Expert Opin Drug Saf. 2017 Apr;16(4):423-428. doi: 10.1080/14740338.2017.1297420. Epub 2017 Feb 24. Expert Opin Drug Saf. 2017. PMID: 28276859

7

Risk of fatigue in cancer patients receiving anti-EGFR monoclonal antibodies: results from a systematic review and meta-analysis of randomized controlled trial.

Zhu J, Zhao W, Liang D, Li G, Qiu K, Wu J, Li J. Zhu J, et al. Int J Clin Oncol. 2018 Apr;23(2):389-399. doi: 10.1007/s10147-017-1218-7. Epub 2017 Nov 27. Int J Clin Oncol. 2018. PMID: 29181651

8

Toxicity profile characteristics of novel androgen-deprivation therapy agents in patients with prostate cancer: a meta-analysis.

Zhu J, Liao R, Su C, Liang D, Wu J, Qiu K, Li J. Zhu J, et al. Expert Rev Anticancer Ther. 2018 Feb;18(2):193-198. doi: 10.1080/14737140.2018.1419871. Epub 2017 Dec 26. Expert Rev Anticancer Ther. 2018. PMID: 29257709

9

Bioequivalence of cefalexin in healthy Chinese subjects.

Lv X, Zhong G, Yao H, Wu J, Ye S. Lv X, et al. Int J Clin Pharmacol Ther. 2021 Nov;59(11):725-733. doi: 10.5414/CP203986. Int J Clin Pharmacol Ther. 2021. PMID: 34448694 Clinical Trial.

10

Triple therapy in the management of chronic obstructive pulmonary disease: systematic review and meta-analysis.

Zheng Y, Zhu J, Liu Y, Lai W, Lin C, Qiu K, Wu J, Yao W. Zheng Y, et al. BMJ. 2018 Nov 6;363:k4388. doi: 10.1136/bmj.k4388. BMJ. 2018. PMID: 30401700 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,617 results

Search Page

Filters